These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo. Guo J; Gao J; Li Z; Gong Y; Man X; Jin J; Wu H Cancer Lett; 2013 Oct; 339(2):185-94. PubMed ID: 23791879 [TBL] [Abstract][Full Text] [Related]
7. NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo. Jalili A; Mertz KD; Romanov J; Wagner C; Kalthoff F; Stuetz A; Pathria G; Gschaider M; Stingl G; Wagner SN PLoS One; 2013; 8(7):e69064. PubMed ID: 23935925 [TBL] [Abstract][Full Text] [Related]
8. LKB1 inhibits breast cancer partially through repressing the Hedgehog signaling pathway. Zhuang Z; Wang K; Cheng X; Qu X; Jiang B; Li Z; Luo J; Shao Z; Duan T PLoS One; 2013; 8(7):e67431. PubMed ID: 23861764 [TBL] [Abstract][Full Text] [Related]
9. Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors. Lee SJ; Do IG; Lee J; Kim KM; Jang J; Sohn I; Kang WK Target Oncol; 2013 Dec; 8(4):271-80. PubMed ID: 23371028 [TBL] [Abstract][Full Text] [Related]
10. Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations. Galimberti F; Busch AM; Chinyengetere F; Ma T; Sekula D; Memoli VA; Dragnev KH; Liu F; Johnson KC; Guo Y; Freemantle SJ; Andrew AS; Greninger P; Robbins DJ; Settleman J; Benes C; Dmitrovsky E Int J Oncol; 2012 Nov; 41(5):1751-61. PubMed ID: 22923130 [TBL] [Abstract][Full Text] [Related]
11. Targeting the cross-talk between the hedgehog and NF-κB signaling pathways in multiple myeloma. Cai K; Na W; Guo M; Xu R; Wang X; Qin Y; Wu Y; Jiang J; Huang H Leuk Lymphoma; 2019 Mar; 60(3):772-781. PubMed ID: 30644322 [TBL] [Abstract][Full Text] [Related]
12. Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment. Heller E; Hurchla MA; Xiang J; Su X; Chen S; Schneider J; Joeng KS; Vidal M; Goldberg L; Deng H; Hornick MC; Prior JL; Piwnica-Worms D; Long F; Cagan R; Weilbaecher KN Cancer Res; 2012 Feb; 72(4):897-907. PubMed ID: 22186138 [TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid antagonizes the Hedgehog pathway by inducing patched. Busch AM; Galimberti F; Nehls KE; Roengvoraphoj M; Sekula D; Li B; Guo Y; Direnzo J; Fiering SN; Spinella MJ; Robbins DJ; Memoli VA; Freemantle SJ; Dmitrovsky E Cancer Biol Ther; 2014 Apr; 15(4):463-72. PubMed ID: 24496080 [TBL] [Abstract][Full Text] [Related]
14. The hedgehog-patched signaling pathway and function in the mammalian ovary: a novel role for hedgehog proteins in stimulating proliferation and steroidogenesis of theca cells. Spicer LJ; Sudo S; Aad PY; Wang LS; Chun SY; Ben-Shlomo I; Klein C; Hsueh AJ Reproduction; 2009 Aug; 138(2):329-39. PubMed ID: 19433502 [TBL] [Abstract][Full Text] [Related]
15. A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance. Liu Z; Xu J; He J; Zheng Y; Li H; Lu Y; Qian J; Lin P; Weber DM; Yang J; Yi Q Blood; 2014 Sep; 124(13):2061-71. PubMed ID: 25049282 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of hedgehog pathway molecules and FOXM1 in non-small cell lung carcinomas. Gialmanidis IP; Bravou V; Amanetopoulou SG; Varakis J; Kourea H; Papadaki H Lung Cancer; 2009 Oct; 66(1):64-74. PubMed ID: 19200615 [TBL] [Abstract][Full Text] [Related]
17. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway. Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells. D'Amato C; Rosa R; Marciano R; D'Amato V; Formisano L; Nappi L; Raimondo L; Di Mauro C; Servetto A; Fulciniti F; Cipolletta A; Bianco C; Ciardiello F; Veneziani BM; De Placido S; Bianco R Br J Cancer; 2014 Sep; 111(6):1168-79. PubMed ID: 25093491 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors. Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616 [TBL] [Abstract][Full Text] [Related]